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Abstract
Background: Despite the sophisticated cross sectional image techniques currently available, a number of biliary
stenosis or obstructions remain of an uncertain nature. In these pathological conditions, an "intrinsic" parietal
alteration is the cause of biliary obstruction and it is very difficult to differentiate benign from malignant lesions
using cross-sectional imaging procedures alone. We evaluated the efficacy of different endoluminal techniques to
achieve a definitive pathological diagnosis in these situations.
Methods: Eighty patients underwent brushing, and or biopsy of the biliary tree through an existing transhepatic
biliary drainage route. A subcoort of 12 patients needed balloon-dilatation of the bile duct and the material
covering the balloon surface was also sent for pathological examination (balloon surface sampling). Pathological
results were compared with surgical findings or with long-term clinical and instrumental follow-ups. Success rates,
sensitivity, specificity, accuracy, confidential intervals, positive predictive value and negative predictive value of the
three percutaneous techniques in differentiating benign from malignant disease were assessed.
The agreement coefficient of biopsy and brushing with final diagnosis was calculated using the Cohen's "K" value.
Results: Fifty-six patients had malignant strictures confirmed by surgery, histology, and by clinical follow-ups.
Success rates of brushing, balloon surface sampling, and biopsy were 90.7, 100, and 100%, respectively. The
comparative efficacy of brushing, balloon-surface sampling, and biopsy resulted as follows: sensitivity of 47.8, 87.5,
and 92.1%, respectively; specificity of 100% for all the techniques; accuracy of 69.2, 91.7 and 93.6%, Positive
Predictive Value of 100% for all the procedures and Negative Predictive Value of 55, 80, and 75%, respectively.
Conclusions: Percutaneous endoluminal biopsy is more accurate and sensitive than percutaneous bile duct
brushing in the detection of malignant diseases (p < 0.01).
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Background
Bile duct dilatation and increasing jaundice are often
onset symptoms of a number of either malignant or
benign pathological conditions.
In most cases, common cross-sectional imaging tech-
niques such as ultrasonography (US) or spiral-CT or
cholangio-pancreatico-biliary magnetic resonance
(MRCP) are highly capable of depicting the causes of
obstruction by simply showing extrinsic masses in case of
infiltrating tumors or benign causes of jaundice, like
stones [1].
These non invasive techniques, however, can still yield
uncertain results in some particular benign or malignant
pathological conditions.
When stones are too small for example, or when bile duct
dilatation is limited. For final confirmation or exclusion
of endobiliary stones ERCP is unavoidable before the sub-
sequent therapeutic steps.
There are also some pathological conditions where an
"intrinsic" parietal alteration is the cause of biliary
obstruction and it is very difficult to distinguish benign
from malignant lesions using cross-sectional imaging pro-
cedures alone (figure 4 - 5).
A biliary dilatation may also occur after surgical interven-
tions involving the biliary system, like bilioenteric anasto-
moses for gastric or pancreatic neoplasms or
cholecystectomies. It is not always possible to distinguish
between a recurrent disease or a fibrotic post-surgical ste-
nosis, especially if it occurs early and if inflammatory
alterations were already present during surgery.
A number of obstructions remains therefore unexplained
because the aforementioned imaging modalities do not
show any extrinsic compressing or infiltrating mass, nor a
calcolous disease.
In these cases, only the intrahepatic bile ducts dilation
and the level of the obstruction can be determined, but
additional diagnostic procedures should be performed for
a diagnosis of the real nature of the obstruction [2].
Patients with obstructive jaundice often undergo percuta-
neous biliary cholangiography and drainage (PBD) for
decompression of the biliary tree.
Although relatively invasive, not even PBD allows to
achieve a definitive differential diagnosis between malig-
nant and benign pathologies.
Tissue sampling becomes therefore essential for the histo-
logical characterization of parietal alterations and for
planning their appropriate treatment [3].
Bile cytology, although easily feasible either through a
transhepatic or an endoscopic route, does not accomplish
adequate pathological diagnoses in most cases [5-7].
In our study, three different endoluminal sampling tech-
niques for the characterization of biliary strictures of
uncertain nature have been reviewed and comparatively
evaluated with the purpose of determining which one of
them is the most accurate for differentiating between
benign or malignant pathology.
Methods
Our investigation was performed on a population of 80
patients who, from January 1992 to September 1999,
underwent endoluminal brushing and/or biopsy for bil-
iary stenosis or obstructions of uncertain nature. A retro-
spective evaluation of the efficacy of these techniques was
carried out by comparing the pathological findings on
one hand and radiological findings, clinical long-term fol-
low ups, and/or post-surgical specimens, on the other.
Patient population included 43 men and 37 women, with
a mean age of 62 years (range 37–87 years). All patients
presented jaundice as a common symptom, weight loss
was present in 20 cases (25%), and itching in 12 cases
(15%).
At admission, all patients presented biliary dilation, but
no masses were identifiable by imaging procedures such
as US, CT, MRCP. ERCP had been performed in 23
patients with middle-low common bile duct stenosis but
the nature of obstruction could not be determined nor a
drainage could be placed.
Obstruction were located at the biliary bifurcation in 18
cases (22.5%), the common extrahepatic bile duct in 50
(62.5%), the right (2) and left (2) hepatic duct in 4 cases
(5%)
Eight patients with bilioenteric anastomoses (10%) were
also evaluated in order to determine the nature of the
stricture. The patients came to the interventional unit
needing for a biliary drainage. PBDs were performed using
standard interventional techniques.[5]
The percutaneous approach was right lateral in all patients
but 25 of them required also an anterior subxyphoid
approach.
The procedures for cytological and/or histological sam-
ples were performed in any case 3–5 days after placementBMC Medical Imaging 2004, 4:3 http://www.biomedcentral.com/1471-2342/4/3
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of the biliary drainage in order to operate on a decom-
pressed biliary system.
One hundred and two endoluminal procedures were
included in this study. Twenty-one patients underwent
cytologic brushing only, 25 endoluminal biopsy only,
and 22 both brushing and biopsy. A total number of 43
brushings and 47 biopsies were performed.
In 12 additional cases, we obtained cytological and tissue
samples from an angioplastic balloon used for the bilio-
plasty of strictures of uncertain nature (balloon surface
sampling) with techniques that will be described.
Sixteen patients underwent brushing only, because the
cholangioscope was not available yet and five because the
diagnosis of malignancy achieved with brushing was con-
sidered sufficient, thus not requiring further diagnostic
workups to planning the appropriate therapy.
All the specimens were collected after PBD thus after
translesional advancement of a 10 French catheter; in 12
particularly heavy stenosis a preliminary balloon dilata-
tion was also accomplished.
Brushing was performed according to the following tech-
nical steps:
- the indwelling biliary drainage catheter was exchanged
over a guide-wire with a 7/9-F. introducer sheath without
valves at the proximal end ("peel-away", William Cook,
Europe)
- a flexible probe (Fig. 3) with a cilindrical brush at the tip,
5 mm in diameter 10 mm in length (Olympus Italia srl.
Code number BC20295010), was advanced through the
sheath until it was beyond the lesion; the sheath was with-
drawn to expose the brush, which was then pulled back
and forth and rotated across the lesion several times under
fluoroscopic control
- the brush was then carefully pulled back to be removed
from the patient into the sheath, to avoid malignant
spreading through the transhepatic tract
-samples were then placed on a glass slide, fixed with
Sprayfix (Surgipath Medical Ind.; Illinois, USA), immedi-
ately submitted for cytological examination and stained
by the standard Papanicolau technique.
Endoluminal forceps biopsy was performed under direct
visualization with a 5-mm. cholangioscope (Olympus
URF. Type P, Japan) (Fig. 1). Sometimes, the site of the
lesion endoscopically visible did not correspond to the
site of the stenosis fluoroscopically detectable; additional
samples were therefore collected under fluoroscopic guid-
ance, according to the following technique:
- the biliary catheter was replaced, over a guide, by a 18-F
"peel-away" introducer sheath through which the cholan-
gioscope was advanced until it was close to the lesion;
- a flexible forceps (5-F. Olympus, FB 185X Fig. 2) was
passed through the working channel of the cholangi-
oscope to obtain 3–4 specimens for each patient;
- the specimens were fixed in a 10%-solution of formaline
and sent to the pathologist, included in paraffin, and dis-
sected in slices of 2–4 microns at microtome; subse-
quently, they were stained by hematoxilyn-eosin, PAS and
Mallory techniques;
- after completion of the biopsy procedures, all the
patients underwent cholangiographic control checking
for contrast material extravasation at the biopsy site and
monitored for symptoms of hemobilia and/or
bacteriemia.
All the patients were submitted to antiobiotic therapy
before and during the three days following endobiliary
procedures.
Twelve patients underwent preliminary bilioplasty
because of the difficulties in advancing the drainage cath-
eter across the biliary stricture. In this group, a different
sampling was performed, based on the examination of
those cells and/or tissue remained stuck to the angioplas-
tic balloon after dilatation (balloon surface sampling):
Flexible cholangioscope (5 mm in diameter) (Olympus, URF,  type P, Japan) Figure 1
Flexible cholangioscope (5 mm in diameter) (Olympus, URF, 
type P, Japan)BMC Medical Imaging 2004, 4:3 http://www.biomedcentral.com/1471-2342/4/3
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- once deflated, the balloon (8–10 mm., Meditech, Bos-
ton, USA) was pulled back into the sheath and removed
from the patient;
- the balloon was then placed in a saline solution with
10% of formalin, inflated and agitated several times to
facilitate detachment of samples, which were then imme-
diately delivered to the pathology laboratory.
Pathological specimens from 14 patients were compared
with open surgery findings and post-surgical pathological
reports. The pathologists, hystologists and cytologists,
were blinded as to corresponding results.
The follow-up of the patients undergone to surgery
stopped after the operation. Patients not candidate to sur-
gery were treated with interventional procedures only
such as bilioplasty, biliary drainage, interstitial
radiotherapy and/or with chemotherapy or just a support-
ive therapy. This group of unoperated patients was fol-
lowed-up on the basis of clinical and radiological data
obtained by case-record reviews and by correspondence
with their referring clinicians and general practitioners.
The follow-up period ranged from 3 to 48 months. A min-
imum of 12 months of healthy negative cytological-histo-
logical diagnosis was necessary because either a clinically
benign stenosing lesion or a cytohistological diagnosis
negative for malignancy must be confirmed by a pro-
longed survival, as well as by clinical and radiological
findings.
Calculations of success rate, sensitivity, specificity, posi-
tive predictive value, and negative predictive value for
each technique were based on the number of biopsy pro-
cedures (n = 102) rather than on the number of patients
(n = 80), (Table 1) since each biopsy was considered as a
separate event The success rate is the percentage of biopsy
procedures resulting in sufficient material for microscopic
evaluation.
Confidential Intervals (CIs) were determined for brushing
and biopsy groups assuming a P value of .01 by using the
Geigy Scientific Table (Geigy, Florence, 1984). The agree-
ment coefficient between biopsy or brushing and final
diagnosis was calculated using the Cohen's "K" value
using SPSS 8.0 for Windows (SPSS, Chicago, Illinois,
1997).
Results and discussion
A final diagnosis of malignant disease was confirmed in
56 (70%) cases and a final diagnosis of benign disease in
24 (30%) cases for an overall of 80 patients.
Final diagnoses in the malignant group included: cholan-
giocarcinoma (n = 31), adenocarcinoma (n = 6), meta-
static adenocarcinoma (n = 5), pancreatic carcinoma (n =
13) and malignant endocrine tumor (n = 1). Final diag-
noses in the benign group included: iatrogenic stenosis (n
= 9), sclerosing cholangitis (n = 12) and primary (N = 2)
and secondary biliary cirrhosis (N = 1).
Thirty-nine of the 43 brushing biopsies procedures were
technically adequate for the diagnostic evaluation. Four
cases were considered "poorly cellular" by the patholo-
gists, with an overall success rate of 90.7% (Table 1).
These 4 cases underwent endoluminal forceps biopsy
within 15 days from the brushing.
Alligator forceps (Olympus, FB 195X, Japan) Figure 2
Alligator forceps (Olympus, FB 195X, Japan). The wire tip is 
open 25
A metallic flexible probe with a cilindrical brush at the atrau- matic tip, 5 mm in diameter 10 mm in length(Olympus Italia  srl. Code number BC2029501) brush (approximately 1 cm in  length and 5 mm in diameter) Figure 3
A metallic flexible probe with a cilindrical brush at the atrau-
matic tip, 5 mm in diameter 10 mm in length(Olympus Italia 
srl. Code number BC2029501) brush (approximately 1 cm in 
length and 5 mm in diameter)BMC Medical Imaging 2004, 4:3 http://www.biomedcentral.com/1471-2342/4/3
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Malignant cells were detected by brushing in 11 cases
including: adenocarcinoma (n = 2), cholangiocarcinoma
(n = 6), pancreatic carcinoma (n = 2), and metastatic ade-
nocarcinoma (n= 1) (table 2).
Of the 32 patients with negative findings for malignant
cells, the 4 cases in whom the samples were considered
"acellular" by the pathologists were excluded by the statis-
tical analysis, as just mentioned. Hence, 16 out of 28 had
a final diagnosis of benign disease confirmed by long-
term clinical follow-up (true negatives) (Table 3) and 12
patients had a final diagnosis of malignancy (false nega-
tives) (Table 4). Therefore, 11 true positives, 16 true
negatives and 12 false negatives were obtained by cytolog-
ical brushing, with an overall sensitivity, specificity, accu-
racy, PPV, and NPV in the detection of malignant diseases
of 47.8, 100, 69.2, 100, and 57.1 % respectively (Table
1,5).
Endoluminal forceps biopsy was performed in 47 cases.
Thirty-five of these were interpreted as containing malig-
nant cells (Table 2): cholangiocarcinoma (n = 18), pan-
creatic carcinoma (n = 10), metastatic adenocarcinoma (n
= 5), adenocarcinoma (n = 1), and neuroendocrine tumor
(n = 1). Nine of the 12 cases interpreted as containing
inflammatory cells were confirmed by clinical and radio-
logical follow-up as follows: sclerosing cholangitis (n =
4), iatrogenic stenosis (n = 3) and biliary cirrhosis (n = 2).
Three cases were erroneously interpreted as benign (false
negative) but the clinical follow-up revealed 2 pancreatic
carcinomas and 1 adenocarcinoma (Table 4). With 35
true positives, 9 true negatives and 3 false negatives,
endoluminal forceps biopsy showed a sensitivity of
92.1%, a specificity of 100%, an accuracy of 93.6%, and a
PPV and NPV of 100 and 75%.
CIs were reported in Table 5. "K" values for biopsy and
brushing vs clinical/surgical final diagnosis were 0.613
and 0.404, respectively (Table 6).
As previously discussed, 12 samples were obtained in as
many patients with an angioplastic balloon after dilation
of biliary strictures (balloon surface sampling). This tech-
nique demonstrated malignant cells in 7 (58.3%) cases
and benign cells in 5 (41.7%). The final clinical diagnosis
of the malignant group included adenocarcinoma (n = 1),
cholangiocarcinoma (n = 5) and pancreatic carcinoma (n
= 1) (Table 2). The final clinical diagnosis of the benign
group included four iatrogenic stenosis (Table 3). In one
case a sclerosing cholangitis was diagnosed by balloon
brushing, but clinical follow-up and further investigations
revealed a cholangiocarcinoma (Table 4). With this tech-
nique, we therefore had 1 false negative, 7 true positives
and 4 true negatives, with a sensitivity, specificity,
accuracy, positive predictive value and negative predictive
value of 87.5, 100, 91.7, 100, 80%, respectively (Table 5).
Twenty-two patients underwent brush cytology together
with endoluminal forceps biopsy. By excluding the 4
patients whose specimens were considered "acellular"
and comparing each procedure with the clinical follow-up
and surgical specimens, we obtained 12 concordant and 6
discordant diagnoses.
In the group of 12 concordant diagnoses, 6 benign dis-
eases, such as primary sclerosing cholangitis (n = 3), iatro-
genic stricture (n = 1) and biliary cirrhosis (n = 2) and 6
malignant diseases, such as cholangiocarcinoma (n = 3),
pancreatic carcinoma (n = 2), and metastatic adenocarci-
noma (n = 1) were included. All concordant diagnoses
were confirmed by clinical or surgical follow-up. In the
group of 6 discordant diagnoses, cholangiocarcinoma (n
= 4) adenocarcinoma (n = 1) and pancreatic carcinoma (n
= 1), were included. All the 6 malignancies misdiagnosed
by brushing were correctly diagnosed by biopsy.
Transient hemobilia (spontaneously reversed from 1 to
12 hours after the procedure), was observed in 5/47
(10.6%) patients who had undergone biopsy.
In 4 of them, particular angulations of the access route
was present and there were difficulties in negotiation of
the stricture.
No major complications directly related to the brush
cytology or the endoluminal forceps biopsy procedures
occurred.
Table 1: Differentiation of biliary obstruction with different percutaneous endoluminal techniques
Technique N. PTS SR TP TN FP FN
Brushing 43 * 39/43 11 16 0 12
Biopsy 47 * 47/47 35 9 0 3
B a l l o o n  B r u s h i n g 1 2 1 2 / 1 2 7401
SR= Success Rate; TP= True Positive; TN= True Negative; FP= false positive; FN= False Negative
*22 patients underwent either brushing and forceps biopsy.BMC Medical Imaging 2004, 4:3 http://www.biomedcentral.com/1471-2342/4/3
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Table 2: True positives
Type of tumour Brushing Biopsy Balloon-brushing
Cholangiocarcinoma 61 8 5
Adenocarcinoma 211
Metastatic adenoca. 15-
Pancreatic carcinoma 21 0 1
Neuroendocrine tumor 1-
Table 3: True negatives
Type of tumor Brushing Biopsy Balloon-brushing
Sclerosing cholangitis 10 4 -
Biliary cirrhosis 32-
Iatrogenic strictures 334
Table 4: False negatives
Type of tumor Brushing Biopsy Balloon-brushing
Cholangiocarcinoma 7- 1
Adenocarcinoma 21-
Pancreatic carcinoma 32-
Table 5: Statistical analysis
Technique Sensitivity Specificity Accuracy PPV NPV
Brushing 47.8% 28.10–69.66* 100% 87.30–100.00* 69.2% 100% 57.1%
Biopsy 92.1% 75.56–98.53* 100% 89.34–100.00* 93.6% 100% 75%
Balloon brushing 87.5% 52.30–99.96* 100% 64.31–100.00* 91.7% 100% 80%
* 99% C.I. (Geigy scientific tables)
Table 6: Cohen's Kappa value
Cohen's Kappa Significance
Brushing vs follow-up 0.404 0.001
Biospy vs follow-up 0.613 0.019BMC Medical Imaging 2004, 4:3 http://www.biomedcentral.com/1471-2342/4/3
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Discussion
The evaluation of patients with biliary tract obstruction
without evidence of any intrahepatic or extrahepatic
growing mass has traditionally involved a variety of diag-
nostic imaging techniques [1]. Ultrasound and CT are
often the initial diagnostic investigation to be performed
and provide good information about the presence of bil-
iary obstructions and the degree of ductal dilatation [8].
These imaging modalities, are however limited in depict-
ing intraductal anatomy and, sometimes, in exactly deter-
mining the level and the cause of the obstruction [1,9].
Magnetic resonance cholangiography (MRC) is a non-
invasive imaging modality providing a good visualization
of the biliary. system. The sensitivity of MRC in the detec-
tion of choledocholithiasis has been reported as 90–
100%, a comparable rate with that of endoscopic retro-
grade cholangiopancreatography (ERCP) [10-15].
The assessment of the level of obstruction also has been
reported as highly accurate [16-19]. However, low-grade
strictures or lesions causing biliary dilation may be missed
by MRC [20]. The pathological characterization of pre-
sumed malignant strictures can be therefore, difficult, if
not impossible, using noninvasive imaging studies alone
in some intrinsic lesions causing biliary dilation. As a final
diagnosis could radically affect further therapeutic choices
histological, an histological characterization is required in
the management of patients with biliary strictures [1].
Fine-needle percutaneous biopsy (FNPB) and fine-needle
aspiration (FNA) has been reported poorly valuable in
absence of a lesion clearly identifiable [21,22]. The tumor
most frequently not identifiable as a true growing mass is
cholangiocarcinoma and the differential diagnosis with
primary sclerosing cholangitis is of somewhat importance
[23]. The differential diagnosis between some carcinomas
of the pancreatic head or small submucosal tumors of the
ampulla and cholangiocarcinoma or inflammatory dis-
eases, such as sclerosing cholangitis, can be very difficult
in many cases. Patients with bilioenteric anastomoses
after tumoral mass resection have a very complex local
anatomic alteration that makes extremely difficult any
radiological investigation searching for small recurrent
neoplastic infiltrations [27].
Treatment protocols require pathological diagnoses for
palliative or possibly curative therapy in almost all these
types of conditions. In addition, the surgical technique
itself can be different if a malignancy is present or not.
Some Authors, when liver transplant is still indicated,
suggest a large excision associated with gastrectomy, pan-
createctomy and a transverse ascending colectomy [25].
Although the efficacy of this surgical approach is still
under debate, the role of a preoperative diagnosis is
extremely important.
Malignant cells surrounding the biliary ducts may contin-
uously exfoliated into the bile, especially in the case of
tumors which breack through the mucosa, and become
available for the cytological examination when the bile is
collected either percutaneously or by ERCP. Cytodiagno-
sis is easy to be performed, atraumatic in nature, with less
A 58 year old man, who 8 years ago underwent left hepatec- tomy and cholecistectomy, for complicated intrahepatic bil- iary stones, presented with jaundice and weight loss Figure 4
A 58 year old man, who 8 years ago underwent left hepatec-
tomy and cholecistectomy, for complicated intrahepatic bil-
iary stones, presented with jaundice and weight loss. 
Enhanced CT scan showed marked intrahepatic biliary 
dilation.
A 68 year-old male patient underwent surgery for  cholangiocarcinoma Figure 5
Same patient as fig 4, at lower level, although, an extrinsic 
mass was not detected, the lumen of CBD appeared replace-
ment by soft tissue mass density (arrows).BMC Medical Imaging 2004, 4:3 http://www.biomedcentral.com/1471-2342/4/3
Page 8 of 10
(page number not for citation purposes)
potential risk and associated with relatively low charges.
This technique has shown low sensitivity (15–28%) and
accuracy (48–58%) rates, due to an early cellular degener-
ation after bile collection and to "poorly cellular" speci-
mens. In addition, some pathological aspects can affect
the efficacy of the procedure, such as in case of lesions
extrinsically compressing the bile duct wall without a
complete transmural infiltration or an adequately wide
mucosal disruption [22]. Endoluminal brush cytology
was successfully performed either percutaneously, by
Radiologists, or endoscopically, by Gastroenterologists
[26-28]. In our experience, brush cytology showed a high
specificity but low sensitivity and accuracy rate in the
detection of malignant diseases. Technical limits were
mostly represented by "poorly cellular samples". In our
study, in fact, 4 cases (9.3%) were considered "poorly cel-
lular" by the pathologists. In addition to these technical
problems, similarly to bile cytology, we have to consider
some morphological aspects that can negatively influence
the sensitivity of this technique.
According also with our cholangioscopic experience, bil-
iary tumors may remain intramural causing an annular
constriction of the biliary duct [21,29] without complete
transmucosal infiltration, and this condition can mimic
sclerosing cholangitis and render brush cytology ineffec-
tive. In light of the fact that there is a frequent relationship
between sclerosing cholangitis and malignant strictures,
the cytological differentiation between inflammatory and
malignant changes can be extremely difficult. In addition,
these tumors are frequently so well differentiated that
their identification as "malignant" can be, even histologi-
cally, difficult [29,30]. These are the theoretical explana-
tions that we can give to the fact that cytological diagnosis
of cholangiocarcinoma yielded a relatively low sensitivity,
verified in our study as well as in the literature [1,21-
23,26,30]. At endoscopic sampling, cholangiocarcinoma
has a higher sensitivity [28]
In this review only patients not suitable for ERCP or com-
ing from a failed drainage or other type of retrograde
endoscopic intervention were evaluated, thus the percuta-
neous and endoscopic techniques can not be compared.
Whenever possible especially if skilled endoscopists are
available, retrograde approach could still to be considered
the first step, for its potentially high sensitivity especially
if repeated sampling are performed [27,28]
Percutaneous brush cytology, if compared with bile
transendoscopic cytodiagnosis, has the potential risk of a
malignant spreading of cells through the transhepatic
tract. To overcome this risk, in our opinion, the brush
should be pulled back and removed from the patient into
the introducer sheath. With this technique, in fact, no
spreading along the transhepatic tract was observed in our
malignant patients at imaging follow-up. Brush cytology
is a easy, safe and at relatively low-cost procedure, simi-
larly to bile collection. A single sampling however has a
low possibility of detecting a malignancy. The results can
improve with multiple samples. Three consecutive nega-
tive samples decrease the probability of a malignancy
from more than 55% to less than 5% [30]. The absence of
false positives in our and others, series [2] means that an
intraductal biopsy has no purpose when an exfoliative
cytology is positive. Meanwhile, in presence of a negative
cytology, other techniques such as percutaneous FNA and
endoluminal forceps biopsy should be mandatory. Fine
needle aspiration performed either percutaneously or
endoscopically has some technical advantages over endo-
luminal brushing in those lesions extrinsically compress-
ing the biliary duct without deeply infiltrating the ductal
wall, since the inner epithelial layer is not involved [21].
Most of these patients with biliary obstruction, especially
with high lesions, however, in our Hospital, usually
undergoes percutaneous biliary drainage in the early
phases of their clinical work-up. A percutaneous FNA
would represent an adjunctive interventional procedure
that could be avoided by using the transhepatic route,
already available. We had adequate percutaneous biopsy
specimens in epithelial lesions, such as cholangiocarci-
noma, and inadequate specimens in those lesions with
inflammatory and/or necrotic changes. The dense fibrotic
and scirrus reaction associated with pancreatic carcinoma
may result in poor biopsies specimens [31]. In addition,
pancreatic carcinoma is often associated with pancreatitis,
necrotic cellular debris and a dense fibrotic reaction which
can further contribute to the disappointing results
obtained with even aggressive percutaneous biopsy tech-
niques [32].
The differentiation degree of a tumor can affect the accu-
racy of the histological classification. In those cases of ext-
rahepatic and periampullary biliary tumors, in fact,
usually highly undifferentiated, the histological character-
ization can be difficult, although a generic diagnosis of
malignancy can be made.
Potential complications due to forceps biopsy, such as
disruption of the ductal wall with consequent bile leak
and bleeding, cholangitis and pancreatitis, are reported
[33].
Endoluminal forceps biopsy especially in patients with
hemobilia or cholangitis, should therefore be performed
in the remission phase of the disease, and, in any case, at
least 5 days after biliary drainage, to avoid the complica-
tions related to manipulations into the biliary tree. No
major complications were observed in this series, neither
from percutaneous brushing nor from forceps biopsy. A
transient hemobilia was observed in 5 patients who hadBMC Medical Imaging 2004, 4:3 http://www.biomedcentral.com/1471-2342/4/3
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undergone biopsy (10.6%). This series, including part of
a previously analyzed smaller population [33] confirms
that percutaneous endoluminal forceps biopsy has a very
high sensitivity (92.1%), specificity (100%), accuracy
(93.6%), PPV (100%), and NPV (75%) in the detection of
malignant diseases (Table 2). The higher accuracy of
biopsy over brushing is very clear, especially analyzing the
data obtained in those patients in whom both techniques
were performed. On the other hand, biopsy presents some
disadvantages, such as the higher costs of the equipment
and the difficult trackability across tight strictures or acute
angles of the biliary ducts.
A high diagnostic value was proven by the simple exami-
nation of tissue samplings coming from balloon dilata-
tion of biliary or bilio-enteric anastomotic strictures
(balloon surface sampling). Although the number of cases
reported in this series is relatively small, it should be con-
sidered that it was possible to distinguish benign from
malignant diseases in almost all the cases. Our suggestion,
therefore is to associate a tissue collection from the bal-
loon to bilioplasty, as a standard procedure when screen-
ing for malignant pancreatobiliary diseases is required. In
this way. it is possible to save time and avoid risks related
to further endobiliary procedures.
Conclusion
Patients with obstructive jaundice, who are candidates for
biliary drainage, often come to the interventional radiolo-
gist still without a definitive diagnosis of the real nature of
their disease, even after high-level cross-sectional imaging
procedures, such as abdominal MR, MRCP or abdominal
spiral-CT. When the clinical diagnosis needs to be histo-
logically confirmed for further therapeutic choices, the
transhepatic route can be successfully used for the
intraductal sampling. Forceps biopsy is highly accurate
under cholangioscopic guidance. As an alternative,
repeated brushings can be performed under fluoroscopy.
If a balloon blioplasty, for any reason, is performed, it is
advisable to collect the tissue fragments on the balloon
surface and send them for pathological evaluation.
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